Heterocyclic modulators of lipid synthesis
US-2024400552-A1 · Dec 5, 2024 · US
US10323033B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10323033-B2 |
| Application number | US-201816004188-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 8, 2018 |
| Priority date | Jun 8, 2017 |
| Publication date | Jun 18, 2019 |
| Grant date | Jun 18, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Provided are an imidazo[1,2-a]pyridine-3-carboxylate derivative and a preparation method thereof, and more particularly, a method of effectively preparing an imidazo[1,2-a]pyridine-3-carboxylate derivative by performing an aza-[3+2] cycloaddition reaction of a pyridine derivative with an α-diazo oxime ether derivative in the presence of a copper (II) catalyst, and an imidazo[1,2-a]pyridine-3-carboxylate derivative prepared thereby.
Opening claim text (preview).
What is claimed is: 1. A preparation method of an imidazo[1,2-a]pyridine-3-carboxylate derivative comprising: performing an aza-[3+2] cycloaddition reaction of a pyridine derivative represented by Chemical Formula 6 below with an α-diazo oxime ether derivative represented by Chemical Formula 7 below in the presence of a copper (II) catalyst, thereby preparing an imidazo[1,2-a]pyridine-3-carboxylate derivative represented by Chemical Formula 1 below: in Chemical Formulas 1, 6, and 7, R 1 is (C1-C10)alkyl, (C6-C12)aryl or (C3-C12)heteroaryl, and the aryl of R 1 may be further substituted with one or more selected from the group consisting of (C1-C10)alkyl, halo(C1-C10)alkyl, (C1-C10)alkoxy, halogen, nitro, (C1-C10)alkylcarbonyl, (C1-C10)alkoxycarbonyl and (C6-C12)aryloxy; R 2 is (C1-C10)alkyl or halo(C1-C10)alkyl; R 3 is (C1-C10)alkoxy; X is CR b or N; Y is CR c or N; Z is CR d or N; R a to R d are each independently hydrogen, (C1-C10)alkyl, halo(C1-C10)alkyl, halogen, (C1-C10)alkylcarbonyl, halo(C1-C10)alkylcarbonyl, (C1-C10)alkoxycarbonyl, halo(C1-C10)alkoxycarbonyl, (C6-C12)aryl(C1-C10)alkyloxy, (C6-C12)aryl or (C3-C12)heteroaryl, or may be linked to an adjacent substituent via —CR 11 ═CR 12 —CR 13 ═CR 14 — to form a fused ring, and the aryl of R a to R d may be further substituted with one or more selected from (C1-C10)alkyl, halo(C1-C10)alkyl, (C1-C10)alkoxy, (C6-C12)aryl and halogen; R 11 to R 14 are each independently hydrogen, (C1-C10)alkyl, halo(C1-C10)alkyl, (C1-C10)alkoxy, (C6-C12)aryl, or halogen; and the heteroaryl includes one to four heteroatoms selected from N, O and S. 2. The preparation method of claim 1 , wherein the copper (II) catalyst is one or two or more selected from the group consisting of Cu(OAc) 2 [Copper(II) acetate], Cu(OTf) 2 [Copper(II) triflate], Cu(acac) 2 [Copper(II) acetylacetonate], Cu(tfacac) 2 [Copper(II) trifluoroacetylacetonate] and Cu(hfacac) 2 [Copper(II) hexafluoroacetylacetonate]. 3. The preparation method of claim 1 , wherein the α-diazo oxime ether derivative represented by Chemical Formula 7 is used in an amount of 1 to 3 equivalents with respect to the pyridine derivative represented by Chemical Formula 6. 4. The preparation method of claim 1 , wherein the copper (II) catalyst is used in an amount of 1 to 20 mol % with respect to the pyridine derivative represented by Chemical Formula 6. 5. The preparation method of claim 1 , wherein the reaction is performed in the presence of one or two or more organic solvents selected from trifluoroethanol, 1,4-dioxane, acetonitrile, toluene, tetrahydrofuran, dimethylformamide, dichloromethane, dichloroethane, N,N-dimethylformamide, hexane, benzene, xylene, chlorobenzene, hexafluorobenzene, octafluorotoluene, tetrabutylalcohol, methanol and ethanol. 6. A preparation method of an imidazo[1,2-a]pyridine-3-carboxylate derivative comprising: performing an aza-[3+2] cycloaddition reaction of a pyridine derivative represented by Chemical Formula 6A below with an α-diazo oxime ether derivative represented by Chemical Formula 7A below in the presence of a copper (II) catalyst in trifluoroethanol, followed by transesterification with trifluoroethanol as a solvent, thereby preparing an imidazo[1,2-a]pyridine-3-carboxylate derivative represented by Chemical Formula 1A below: in Chemical Formulas 1A, 6A, and 7A, R 1 is (C1-C10)alkyl or (C6-C12)aryl, and the aryl of R 1 may be further substituted with one or more selected from the group consisting of (C1-C10)alkyl, (C1-C10)alkoxy, halogen, nitro and (C1-C10)alkoxycarbonyl; R 2 is (C1-C10)alkyl; Y is CR c or N; R 3 is (C1-C10)alkoxy; R a is hydrogen, (C1-C10)alkyl or (C6-C12)aryl(C1-C10)alkyloxy; R b is (C1-C10)alkyl or (C6-C12)aryl, and the aryl of R b may be further substituted with one or more selected from (C1-C10)alkyl and halogen; and R c is hydrogen or (C1-C10)alkyl. 7. The preparation method of claim 6 , wherein the copper (II) catalyst is one or two or more selected from the group consisting of Cu(OAc) 2 [Copper(II) acetate], Cu(OTf) 2 [Copper(II) triflate], Cu(acac) 2 [Copper(II) acetylacetonate], Cu(tfacac) 2 [Copper(II) trifluoroacetylacetonate], and Cu(hfacac) 2 [Copper(II) hexafluoroacetylacetonate]. 8. The preparation method of claim 6 , wherein the α-diazo oxime ether derivative represented by Chemical Formula 7A is used in an amount of 1 to 3 equivalents with respect to the pyridine derivative represented by Chemical Formula 6A. 9. The preparation method of claim 6 , wherein the copper (II) catalyst is used in an amount of 1 to 20 mol % with respect to the pyridine derivative represented by Chemical Formula 6A.
Copper · CPC title
being perfluorinated, i.e. comprising at least one perfluorinated moiety as substructure in case of polyfunctional compounds · CPC title
Ortho-condensed systems · CPC title
ortho- or peri-condensed with heterocyclic rings · CPC title
Compounds containing methylenedioxyphenyl groups, e.g. sesamin · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.